Investors Are Betting Big Against This Marijuana Stock — Are They Wrong?

0
192

GW Pharmaceuticals PLC NASDAQ GWPH has a lot going right at the moment Its cannabis derived epilepsy tincture is one of the most highly anticipated potential drug launches this year Epidiolex scored high marks in pivotal trials underpinning an application under review at the

Source